Although only coming across this company recently, it’s really interesting work they are doing. I’m a strong supporter of companies that are coming up with innovative ways of beating cancer. Ones that are showing signs of progress and adoption are worth looking into for investments. The headline from a press release in January really says it all: “Theralase Technologies Research Successfully Destroys Breast Cancer Cells.” (source). It’s very early stages at this point but the earlier the entry, the more participation an investor can enjoy.

Theralase Technologies Inc. (TSXV:TLT & OTCBB:TLTFF) designs, develops and manufactures patented, super-pulsed laser technology used in a wide range of bio-stimulation and bio-destruction clinical applications. The Theralase technology platform targets several diverse healthcare sectors firstly, for non-invasive pain management and clinical therapy, in hundreds of neural muscular skeletal conditions, (including arthritis) secondly, to bio-stimulate and accelerate wound care and healing, (including; bone fracture regeneration and osteoarthritic conditions) and thirdly, combining photodynamic compounds with super-pulsed, biofeedback laser technology to attack specifically targeted cancers, bacterium, viruses and fat cells.

Theralae Technologies website

SEDAR Filings

1 year chart:

Although the technology is a bit cumbersome to understand unless you’re a bio major, here’s a video of the Theralase product for healing damaged tissue. Pretty cool stuff.

Technorati Tags: canadian penny stocks, Company Profile, penny stock pick, small cap, stock market